Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
作者： Michel De Bandt , , Jean Sibilia , Xavier Le Loët , Sebastian Prouzeau
DOI: 10.1186/AR1715
关键词: Etanercept 、 Tumor necrosis factor alpha 、 Infliximab 、 Lupus erythematosus 、 Retrospective cohort study 、 Oncology 、 Immunology 、 Drug-induced lupus erythematosus 、 Medicine 、 Systemic lupus erythematosus 、 Internal medicine 、 Adverse effect 、 Immunology and Allergy 、 Rheumatology
摘要: The development of drug-induced lupus remains a matter concern in patients treated with anti-tumour necrosis factor (TNF) alpha. incidence such adverse effects is unknown. We undertook retrospective national study to analyse patients.
biomedcentral.com
paperity.org
springer.com参考文章(19)
Anne-Barbara Mongey, Evelyn V. Hess, 45 – DRUG AND ENVIRONMENTAL LUPUS: CLINICAL MANIFESTATIONS AND DIFFERENCES Systemic Lupus Erythematosus (Fourth Edition). pp. 1211- 1237 ,(2004) , 10.1016/B978-012433901-9/50048-X
Ravinder Maini, E William St Clair, Ferdinand Breedveld, Daniel Furst, Joachim Kalden, Michael Weisman, Josef Smolen, Paul Emery, Gregory Harriman, Marc Feldmann, Peter Lipsky, Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial The Lancet. ,vol. 354, pp. 1932- 1939 ,(1999) , 10.1016/S0140-6736(99)05246-0
S.A. Devos, N. van den Bossche, M. De Vos, J.M. Naeyaert, Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy Dermatology. ,vol. 206, pp. 388- 390 ,(2003) , 10.1159/000069965
G Ferraccioli, F Mecchia, E Di Poi, M Fabris, Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections. Annals of the Rheumatic Diseases. ,vol. 61, pp. 358- 361 ,(2002) , 10.1136/ARD.61.4.358
T Jonsdottir, J Forslid, A Van Vollenhoven, A Harju, S Brannemark, L Klareskog, RF Van Vollenhoven, Treatment with tumour necrosis factor α antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies Annals of the Rheumatic Diseases. ,vol. 63, pp. 1075- 1078 ,(2004) , 10.1136/ARD.2003.018093
David S. Pisetsky, Tumor necrosis factor α blockers and the induction of anti‐DNA autoantibodies Arthritis & Rheumatism. ,vol. 43, pp. 2381- 2382 ,(2000) , 10.1002/1529-0131(200011)43:11<2381::AID-ANR1>3.0.CO;2-M
Beatrice Cambien, Wolfgang Bergmeier, Simin Saffaripour, Heather A. Mitchell, Denisa D. Wagner, Antithrombotic activity of TNF-α Journal of Clinical Investigation. ,vol. 112, pp. 1589- 1596 ,(2003) , 10.1172/JCI19284
F. D'Auria, P. Rovere-Querini, M. Giazzon, P. Ajello, E. Baldissera, A. A. Manfredi, M. G. Sabbadini, Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-α antibodies Journal of Internal Medicine. ,vol. 255, pp. 409- 418 ,(2004) , 10.1111/J.1365-2796.2003.01298.X
Marc C. Hochberg, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism. ,vol. 40, pp. 1725- 1725 ,(1997) , 10.1002/ART.1780400928
Elise Carlson, Naomi Rothfield, Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis. Arthritis & Rheumatism. ,vol. 48, pp. 1165- 1166 ,(2003) , 10.1002/ART.11033